Pneumococcal conjugate vaccines: A hope for France?;Les vaccins antipneumococciques conjugues: Un espoir pour la France?

Medecine Therapeutique

Volumn 6, Issue 4, 2000, Pages 270-273

  Reinert, Philippe ^a   Hau Rainsard, Isabelle ^a   Ovetckine, Philippe ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

BACTEREMIA; BACTERIAL MENINGITIS; FRANCE; HEALTH PROMOTION; HUMAN; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; SHORT SURVEY; STREPTOCOCCUS INFECTION;

EID: 0034042933     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (11)

1. Bulletin épidémiologique hebdomadaire, 13/04/99.
2. Cohen R., Geslin P. 1997. La résistance aux antibiotiques modifie-t-elle le pronostic des méningites et des otites moyennes aiguës à S. Pneuymoniae? Med Mal Infect 27 : 496-501.
3. Ahman H., Kayhty H., Lehtonen H., Leroy O., Froeschle J., Eskola J. 1998. Streptococcus pneumoniae capsular polysaccharide-diphteria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J 17 : 211-216.
4. Eskola J, Kayhty H. 1995. New vaccines for prevention of pneumococcal infections. Ann Med 27 : 53-56.
5. Paradiso P.R., Lindberg A.A. 1996. Glycoconjugate vaccines : future combinations. Dev Biol Stand 176 : 269-275.
6. Schneerson R., et al. 1986. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and Pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect immun 52 : 519-528.
7. Steinhoff M.C., et al. 1994. A randomized comparison of three bivalent Streptococcus Pneumoniae glycoprotein conjugate vaccines in young children : effects of polysaccharide size and linkage characteristics. Pediatr Infect Dis J 13 : 368-372.
8. Anderson A.L., Kennedy D.J., Geldmacher K.M., Donnelly J., Mendelman P.M. 1996. Immunogenicity of heptavelent pneumococcal conjugate vaccine in infants. J Pediatr 128 (part 1) : 649-653.
9. Black S. 1998. Efficacy of heptvalent conjugate pneumococcal vaccine in 37 000 children. 38th ICAAC.
10. Dagan R., Muallem M., Melamed R., Leroy O., Yagupsky P. 1997. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravelent pneumococcal vaccines conjugated to either tetanus toxoid or diphteria toxoid. Pediatr Infect Dis J 129 : 1060-1064.
11. Steinhoff M. 1993. Developing and deploying pneumococcal and haemophilus vaccines. Lancet 342 : 630-631.